| #402 |
Mikael Pittet |
The General Hospital |
1 |
| #402 |
Tetsuya Ishino |
Pfizer |
1 |
| #402 |
Khaled Elsaid |
Lubris |
1 |
| #402 |
Behnam Nabet |
Dana-Farber Cancer Institute |
1 |
| #402 |
Wenjun Xiong |
Harvard University |
1 |
| #402 |
Mehmet Umut Caglar |
State Street |
1 |
| #402 |
Jing-Ta Chow |
Ebay |
1 |
| #402 |
Michael March Schmidt |
Compass Therapeutics |
1 |
| #402 |
J. Hastings Granbery |
PayPal |
1 |
| #402 |
Conor L. Evans |
The General Hospital |
1 |
| #402 |
Yifat MERBL |
Harvard University |
1 |
| #402 |
Theresa Tokesky |
Rovi Guides |
1 |
| #402 |
Elizabeth Renfer |
ExxonMobil |
1 |
| #402 |
Georgia Hitzke |
Hologic |
1 |
| #402 |
Benjamin Harris Weinberg |
Boston University |
1 |
| #402 |
Jenna L. Balestrini |
Draper Laboratory |
1 |
| #402 |
Meena Siddiqui |
The General Hospital |
1 |
| #402 |
David Hauser |
CEA |
1 |
| #402 |
Irfan Bulu |
Schlumberger Technology |
1 |
| #402 |
Tommaso Poggioli |
Harvard University |
1 |
| #402 |
Pedro Gaspar |
State Street |
1 |
| #402 |
Steven James Mentzer |
Brigham and Women's Hospital |
1 |
| #402 |
Carl Marci |
The Nielsen Company (Us) |
1 |
| #402 |
Anna Greka |
Brigham and Women's Hospital |
1 |
| #402 |
Norzehan Abdul-Manan |
Vertex Pharmaceuticals Incorporated |
1 |
| #402 |
Brian Tinkham |
Boston Scientific Scimed |
1 |
| #402 |
Christopher Auld |
Formlabs |
1 |
| #402 |
Kent R. Larson |
Dow Corning |
1 |
| #402 |
Russell R. Hoover |
Vertex Pharmaceuticals Incorporated |
1 |
| #402 |
Jack B. Sattell |
Cerevasc |
1 |
| #402 |
Guillaume Adelmant |
Dana-Farber Cancer Institute |
1 |
| #402 |
William Robb Stewart |
GE |
1 |
| #402 |
Christopher Necklas |
Unknown |
1 |
| #402 |
Chaomin Li |
Merck |
1 |
| #402 |
Soumya Ghosh |
IBM |
1 |
| #402 |
Johnny Chung Leung Chu |
AMD |
1 |
| #402 |
Alan Xinyu Guo |
Microsoft |
1 |
| #402 |
Scott Kokones |
Intel |
1 |
| #402 |
Cameron Cecil |
Covidien Lp |
1 |
| #402 |
Vincent J. Morgan |
Diro |
1 |
| #402 |
Caleb J. Siefert |
The Nielsen Company (Us) |
1 |
| #402 |
Jonathan Abraham |
Children'S Medical Center |
1 |
| #402 |
Iulia A. Neagu |
Aon Risk Services, Inc. Of Maryland |
1 |
| #402 |
Kale T. Rogers |
— |
1 |
| #402 |
Sumit Nagpal |
AMD |
1 |
| #402 |
John W. Hoppin |
Invicro |
1 |
| #402 |
Riley W. Crane |
Path |
1 |
| #402 |
Madhavi Jagdish |
Pearl Therapeutics |
1 |
| #402 |
Jack Macy |
Pearl Therapeutics |
1 |
| #402 |
Griffin Crafts |
Pearl Therapeutics |
1 |